Indo US Bio-Tech
NSE: INDOUS · Other Agricultural Products
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Indo US Bio-Tech's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Indo US Bio-Tech Ltd is an agricultural company focused on the research, development, production, and processing of commercial and vegetable seeds. The firm specialises in breeding, packing, and marketing both hybrid and open-pollinated crop varieties.
Business Model
The company generates revenue through the end-to-end management of the seed value chain, including proprietary R&D, seed multiplication, and the distribution of agricultural seeds to farmers.
Growth Outlook
Growth is primarily driven by the expansion of their hybrid seed portfolio and continuous investment in crop research and breeding programmes to improve yield performance.
Key Risks
- Climatic Dependency. The company's performance is highly sensitive to unpredictable weather patterns and monsoon cycles which directly impact agricultural output.
- Regulatory Risk. The seed industry is subject to stringent government regulations regarding pricing, intellectual property, and the approval of genetically modified or hybrid varieties.
- Pest and Disease Outbreaks. Unforeseen crop diseases or pest infestations can significantly damage seed production cycles and inventory quality.
- Market Competition. The agricultural sector faces intense competition from both large multinational corporations and numerous local players, putting pressure on margins.
Start your research today
Unlock AI insights, financials, peers and live data on Indo US Bio-Tech and 5,000+ companies — free.
Key Metrics
P/E
8.6x
Q4 FY26 · standalone
EV/EBITDA
8.3x
Q4 FY26 · standalone
NET PROFIT MARGIN
7.6%
Q4 FY26 · standalone
DEBT TO EQUITY
0.4x
Q4 FY26 · standalone
Peers · Other Agricultural Products
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Indo US Bio-TechINDOUS | ₹157 Cr | 8.64 | 8.32 | — | 16.0% | 21.7% | 25.4% | -44.2% |
Bombay Super Hybrid Seeds LimitedBSHSL | ₹898 Cr | 30.42 | 26.04 | 8.0% | 10.1% | 24.3% | 30.9% | -33.9% |
Mangalam Global Enterprise LimitedMGEL | ₹510 Cr | 10.65 | 8.83 | 41.4% | 2.3% | 19.0% | 34.2% | -10.3% |
Sukhjit Starch & Chemicals LimitedSUKHJITS | ₹508 Cr | 13.80 | 7.61 | -0.9% | 7.5% | 6.2% | 10.2% | -7.6% |
Modi NaturalsMODINATUR | ₹469 Cr | 8.20 | 8.00 | 7.3% | 10.9% | 35.6% | 29.7% | -23.4% |
Sarveshwar FoodsSARVESHWAR | ₹451 Cr | 6.25 | 9.78 | 16.4% | 5.1% | 8.4% | 17.4% | -43.9% |
As of Q4 FY26
Financials
Indo US Bio-Tech
NSE: INDOUS · Other Agricultural Products
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Indo US Bio-Tech's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Indo US Bio-Tech Ltd is an agricultural company focused on the research, development, production, and processing of commercial and vegetable seeds. The firm specialises in breeding, packing, and marketing both hybrid and open-pollinated crop varieties.
Business Model
The company generates revenue through the end-to-end management of the seed value chain, including proprietary R&D, seed multiplication, and the distribution of agricultural seeds to farmers.
Growth Outlook
Growth is primarily driven by the expansion of their hybrid seed portfolio and continuous investment in crop research and breeding programmes to improve yield performance.
Key Risks
- Climatic Dependency. The company's performance is highly sensitive to unpredictable weather patterns and monsoon cycles which directly impact agricultural output.
- Regulatory Risk. The seed industry is subject to stringent government regulations regarding pricing, intellectual property, and the approval of genetically modified or hybrid varieties.
- Pest and Disease Outbreaks. Unforeseen crop diseases or pest infestations can significantly damage seed production cycles and inventory quality.
- Market Competition. The agricultural sector faces intense competition from both large multinational corporations and numerous local players, putting pressure on margins.
Start your research today
Unlock AI insights, financials, peers and live data on Indo US Bio-Tech and 5,000+ companies — free.
Key Metrics
P/E
8.6x
Q4 FY26 · standalone
EV/EBITDA
8.3x
Q4 FY26 · standalone
NET PROFIT MARGIN
7.6%
Q4 FY26 · standalone
DEBT TO EQUITY
0.4x
Q4 FY26 · standalone
Peers · Other Agricultural Products
As of Q4 FY26